Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine TumorGiuseppe Lamberti, Davide Campana, Toni Ibrahim et al.|The Journal of Clinical Endocrinology & Metabolism|2019Cited by 41
Safety of high doses of somatostatin analogs in well differentiated NENs in elderlyMassimiliano Cani, Giuseppe Badalamenti, Lorena Incorvaia et al.|Annals of Oncology|2019Cited by 0